EGFR/ErbB-2/ErbB-4 inhibitor-3

CAT:
804-HY-103440-01
Size:
5 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
EGFR/ErbB-2/ErbB-4 inhibitor-3 - image 1

EGFR/ErbB-2/ErbB-4 inhibitor-3

  • UNSPSC Description:

    EGFR/ErbB-2/ErbB-4 inhibitor-3 (compound 29) is a potent tyrosine kinase inhibitor with IC50s of 0.3, 1.1, 0.5, 2.5, 24 nM for erbB1, erbB2, erbB4, EGF, HER, respectively[1]. EGFR/ErbB-2/ErbB-4 inhibitor-3 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
  • Target Antigen:

    EGFR
  • Type:

    Reference compound
  • Related Pathways:

    JAK/STAT Signaling;Protein Tyrosine Kinase/RTK
  • Applications:

    Cancer-Kinase/protease
  • Field of Research:

    Cancer
  • Assay Protocol:

    https://www.medchemexpress.com/egfr-erbb-2-erbb-4-inhibitor-3.html
  • Purity:

    98.19
  • Solubility:

    DMSO : 25 mg/mL (ultrasonic;warming;heat to 60°C)
  • Smiles:

    O=C(C#CC)NC1=CC(C(NC(C=C2)=CC(Cl)=C2F)=NC=N3)=C3C=N1
  • Molecular Weight:

    355.75
  • References & Citations:

    [1]Klutchko SR, et al. Tyrosine kinase inhibitors. 19. 6-Alkynamides of 4-anilinoquinazolines and 4-anilinopyrido[3,4-d]pyrimidines as irreversible inhibitors of the erbB family of tyrosine kinase receptors. J Med Chem. 2006 Feb 23;49(4):1475-85.
  • Shipping Conditions:

    Room Temperature
  • Storage Conditions:

    -20°C, 3 years; 4°C, 2 years (Powder)
  • Clinical Information:

    No Development Reported
  • CAS Number:

    881001-19-0